Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
lightheadedness	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
HTN	O
who	O
woke	O
up	O
with	O
lightheadedness,	O
presyncope	O
and	O
n/v	O
this	O
morning.	O
She	O
was	O
taken	O
to	O
___	O
and	O
was	O
found	O
to	O
be	O
in	O
"sinus	O
bradycardia	O
to	O
25"	O
per	O
report	O
(no	O
EKG	O
available	O
from	O
___.	O
She	O
was	O
given	O
1L	O
NS	O
and	O
0.5	O
of	O
atropine	O
and	O
went	O
to	O
a	O
fib	O
with	O
RVR	O
at	O
150.	O
She	O
denies	O
having	O
had	O
any	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
For	O
her	O
afib,	O
she	O
received	O
a	O
total	O
of	O
30	O
mg	O
IV	O
of	O
diltiazem	O
with	O
good	O
response.	O
Upon	O
presentation	O
here	O
denies	O
f/c,	O
nausea/vomiting,	O
headache,	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
She	O
still	O
complains	O
of	O
some	O
lightheadedness	O
that	O
is	O
not	O
changed	O
by	O
position.	O
Also	O
complains	O
of	O
some	O
urinary	O
frequency	O
but	O
no	O
dysuria.	O
In	O
___,	O
she	O
was	O
given	O
full	O
dose	O
aspirin	O
and	O
started	O
on	O
dilt	O
drip	O
at	O
10	O
mg/hr	O
at	O
0750.	O
Vitals	O
on	O
transfer:	O
T	O
97.0	O
HR	O
119,	O
RR	O
21,	O
BP	O
115/49,	O
O2	O
Sat	O
95%	O
4	O
LNC.	O
On	O
arrival	O
to	O
the	O
floor,	O
patient's	O
vitals	O
were	O
97.5	O
124/74	O
106	O
(90-140s)	O
20	O
93%	O
RA.	O
Patient	O
is	O
feeling	O
comfortable,	O
no	O
chest	O
pain	O
and	O
shortness	O
of	O
breath,	O
slight	O
lightheadedness.	O
Of	O
note,	O
she	O
recalls	O
a	O
similar	O
episode	O
of	O
lightheadedness	O
and	O
feeling	O
like	O
she	O
is	O
going	O
to	O
faint	O
about	O
___	O
year	O
ago.	O
She	O
had	O
gone	O
to	O
___	O
at	O
that	O
time	O
as	O
well	O
and	O
they	O
gave	O
her	O
IV	O
fluid	O
and	O
discharged	O
her	O
because	O
her	O
symptoms	O
had	O
resolved.	O
REVIEW	O
OF	O
SYSTEMS	O
On	O
review	O
of	O
systems,	O
she	O
denies	O
any	O
prior	O
history	O
of	O
stroke,	O
TIA,	O
deep	O
venous	O
thrombosis,	O
pulmonary	O
embolism,	O
bleeding	O
at	O
the	O
time	O
of	O
surgery,	O
myalgias,	O
joint	O
pains,	O
cough,	O
hemoptysis,	B-Upper_gastrointestinal_haemorrhage
black	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
red	B-Lower_gastrointestinal_haemorrhage
stools.	B-Lower_gastrointestinal_haemorrhage
She	O
denies	O
recent	O
fevers,	O
chills	O
or	O
rigors.	O
She	O
denies	O
exertional	O
buttock	O
or	O
calf	O
pain.	O
+urinary	O
frequency,	O
denies	O
dysuria.	O
Cardiac	O
review	O
of	O
systems	O
is	O
notable	O
for	O
absence	O
of	O
chest	O
pain,	O
dyspnea	O
on	O
exertion,	O
paroxysmal	O
nocturnal	O
dyspnea,	O
orthopnea,	O
ankle	O
edema,	O
palpitations,	O
or	O
syncope.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
(-)Diabetes,	O
(-)Dyslipidemia,	O
(+)Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
-CABG:	O
none	O
-PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
none	O
-PACING/ICD:	O
none	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
hypertension	O
-	O
colon	O
polyp	O
-	O
prolapsed	O
valve	O
-	O
cataract	B-Visual_impairment
(L	O
eye)	O
Social	O
History:	O
___	O
Family	O
History:	O
Brother	O
died	O
of	O
"massive	O
heart	O
attack"	O
in	O
his	O
___.	O
No	O
family	O
history	O
of	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
VS:	O
97.5	O
124/74	O
106	O
20	O
93%	O
RA	O
GENERAL:	O
WDWN	O
lady	O
in	O
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric,	O
L	O
cornea	B-Visual_impairment
hazy/cloudy	B-Visual_impairment
with	O
slight	O
ptosis	O
(old	O
per	O
patient).	O
PERRL	O
(right),	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
MMM.	O
No	O
xanthalesma.	O
NECK:	O
Supple	O
with	O
JVP	O
at	O
clavicle	O
sitting	O
up.	O
CARDIAC:	O
irregularly	O
irregular,	O
slightly	O
tachycardic,	O
normal	O
S1/S2.	O
No	O
m/r/g.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Unlabored	O
respiration.	O
CTAB,	O
bibasilar	O
crackles,	O
no	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM.	O
EXTREMITIES:	O
No	O
c/c/e.	O
DP	O
2+	O
bilaterally.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
DISCHARGE	O
EXAM:	O
VS:	O
98.4	O
147/80	O
58	O
18	O
95%	O
RA	O
CARDIAC:	O
regular	O
rate	O
and	O
rhythm,	O
no	O
murmurs.	O
Rest	O
of	O
the	O
exam	O
unchanged.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
10:40AM	O
BLOOD	O
WBC-6.1	O
RBC-5.00	O
Hgb-14.5	O
Hct-41.9	O
MCV-84	O
MCH-29.0	O
MCHC-34.6	O
RDW-13.1	O
Plt	O
___	O
___	O
10:40AM	O
BLOOD	O
Glucose-127*	O
UreaN-13	O
Creat-0.8	O
Na-143	O
K-3.9	O
Cl-106	O
HCO3-30	O
AnGap-11	O
___	O
10:40AM	O
BLOOD	O
Calcium-8.6	O
Phos-3.5	O
Mg-2.1	O
DISCHARGE	O
LABS:	O
___	O
06:40AM	O
BLOOD	O
Glucose-108*	O
UreaN-14	O
Creat-0.7	O
Na-143	O
K-3.8	O
Cl-105	O
HCO3-28	O
AnGap-14	O
CARDIAC	O
ENZYME:	O
___	O
10:40AM	O
BLOOD	O
CK-MB-4	O
cTropnT-<0.01	O
TSH:	O
___	O
10:40AM	O
BLOOD	O
TSH-1.3	O
MICROBIOLOGY:	O
UA	O
___:	O
Blood-NEG	O
Nitrite-NEG	O
Protein-NEG	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-7.0	O
Leuks-NEG	O
UCX:	O
Mixed	O
flora,	O
likely	O
contaminated.	O
IMAGING:	O
TTE	O
___:	O
The	O
left	O
atrium	O
is	O
elongated.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	O
mitral	O
regurgitation.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
The	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Normal	O
biventricular	O
cavity	O
sizes	O
with	O
preserved	O
global	O
and	O
regional	O
biventricular	O
systolic	O
function.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
F	O
with	O
HTN	O
who	O
presented	O
with	O
symptomatic	O
bradycardia	O
to	O
___	O
at	O
___,	O
given	O
atropine	O
0.5	O
mg	O
and	O
changed	O
to	O
afib	O
with	O
RVR,	O
which	O
was	O
controlled	O
with	O
IV	O
diltiazem	O
bolus	O
and	O
gtt.	O
Patient	O
converted	O
to	O
sinus	O
rhythm	O
and	O
remained	O
in	O
it	O
overnight.	O
Decision	O
was	O
made	O
to	O
monitor	O
the	O
patient	O
with	O
holter	O
monitor	O
and	O
Zio	O
Patch	O
given	O
that	O
patient	O
has	O
not	O
had	O
dangerous	O
arrhythmia	O
causing	O
syncope	O
(pt	O
just	O
noted	O
mild	O
lightheadedness	O
when	O
she	O
was	O
in	O
afib	O
with	O
RVR)	O
and	O
to	O
defer	O
decision	O
about	O
pacemaker	O
placement	O
until	O
after	O
the	O
study.	O
Patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
a	O
cardiologist	O
in	O
___	O
and	O
was	O
given	O
an	O
appointment.	O
#	O
Rhythm:	O
patient	O
with	O
report	O
of	O
"sinus	O
bradycardia"	O
from	O
___,	O
but	O
no	O
strips	O
or	O
EKGs	O
seen.	O
On	O
admission,	O
patient	O
was	O
in	O
atrial	O
fibrillation	O
with	O
RVR,	O
rate	O
controlled	O
with	O
IV	O
diltiazem.	O
She	O
spontaneously	O
converted	O
to	O
sinus	O
rhythm	O
and	O
remained	O
in	O
sinus	O
overnight	O
without	O
further	O
medication.	O
Given	O
the	O
history	O
of	O
sinus	O
bradycardia	O
is	O
unclear	O
and	O
etiology	O
could	O
not	O
be	O
pointed	O
to	O
increased	O
vagal	O
tone	O
vs.	O
heart	O
block,	O
decision	O
was	O
made	O
to	O
defer	O
the	O
pacemaker	O
placement	O
until	O
further	O
data	O
could	O
be	O
gathered	O
from	O
her	O
Holter	O
and	O
Zio	O
Patch	O
monitoring.	O
Echocardiogram	O
was	O
obtained	O
and	O
did	O
not	O
show	O
evidence	O
of	O
tachycardia	O
induced	O
cardiomyopathy.	O
TSH	O
and	O
cardiac	O
enzymes	O
were	O
checked	O
neither	O
of	O
them	O
showed	O
evidence	O
of	O
hyperthyroidism	O
or	O
ischemia.	O
Patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
a	O
cardiologist	O
in	O
___	O
___	O
for	O
further	O
assessment	O
and	O
plan	O
re:	O
medication	O
vs.	O
pacemaker	O
placement	O
in	O
the	O
future.	O
#	O
HTN:	O
Her	O
amlodipine	O
was	O
initially	O
held	O
given	O
her	O
low	O
blood	O
pressure	O
on	O
diltiazem.	O
She	O
became	O
more	O
hypertensive	O
on	O
day	O
2	O
of	O
hospitalization	O
and	O
was	O
restarted	O
on	O
amlodipine	O
10	O
mg	O
daily	O
with	O
good	O
effect.	O
#	O
Urinary	O
frequency:	O
UA	O
checked	O
and	O
negative	O
for	O
UTI.	B-Urinary_tract_infection
#	O
Nutrition:	O
Continued	O
on	O
home	O
multivitamin	O
and	O
omega	O
3	O
Medications	O
on	O
Admission:	O
-	O
Norvasc	O
10	O
mg	O
daily	O
-	O
aspirin	O
81	O
mg	O
daily	O
-	O
multivitamin	O
daily	O
-	O
vitamin	O
B	O
daily	O
-	O
omega	O
3	O
daily	O
Discharge	O
Medications:	O
1.	O
amlodipine	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
2.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
omega-3	O
fatty	O
acids	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
DAILY	O
(Daily).	O
4.	O
aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
once	O
a	O
day.	O
5.	O
Vitamin	O
B	O
Complex	O
Oral	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
atrial	O
fibrillation,	O
atrial	O
tachycardia	O
Secondary	O
Diagnosis:	O
Hypertension	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
___	O
was	O
a	O
pleasure	O
to	O
take	O
care	O
of	O
you	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
of	O
your	O
fast	O
heart	O
rate.	O
You	O
were	O
given	O
medications	O
to	O
control	O
your	O
heart	O
rate	O
and	O
then	O
your	O
heart	O
spontaneously	O
converted	O
back	O
to	O
normal	O
sinus	O
rhythm.	O
You	O
were	O
monitored	O
on	O
telemetry	O
overnight	O
without	O
a	O
repeat	O
event.	O
It	O
was	O
decided	O
that	O
we	O
would	O
monitor	O
you	O
with	O
a	O
heart	O
monitor	O
as	O
an	O
outpatient	O
so	O
we	O
can	O
see	O
if	O
your	O
heart	O
goes	O
in	O
and	O
out	O
of	O
the	O
fast	O
rhythm,	O
which	O
may	O
need	O
different	O
medications	O
and	O
pacemaker	O
in	O
the	O
future.	O
You	O
are	O
being	O
sent	O
home	O
with	O
two	O
different	O
kind	O
of	O
monitors.	O
Please	O
wear	O
the	O
holter	O
monitor	O
and	O
Zio	O
patch	O
as	O
directed	O
and	O
return	O
them	O
to	O
appropriate	O
places.	O
Please	O
follow	O
up	O
with	O
Dr.	O
___	O
Dr.	O
___	O
new	O
cardiologist)	O
as	O
listed	O
below.	O
Dr.	O
___	O
will	O
be	O
in	O
touch	O
with	O
electrophysiologists	O
here	O
and	O
will	O
let	O
you	O
know	O
about	O
further	O
options	O
regarding	O
whether	O
or	O
not	O
you	O
need	O
a	O
pacemaker.	O
No	O
change	O
has	O
been	O
made	O
to	O
your	O
medications.	O
Followup	O
Instructions:	O
___	O

